The US Food and Drug Administration has proposed and finalized several guidance documents that improve and clarify review and inspection processes.
Among these, the agency's internal guidance on preapproval and surveillance inspections now conforms to recent guidance to industry; guidance on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?